Neuranix aims to improve the quality of life of patients with hearing disorders through innovative proprietary technologies.
Neuranix was founded in 2017 by med-tech leaders committed to the development, manufacturing, and commercialization of high-tech devices for the diagnosis of ear diseases in human and veterinary medicine.
Today, Neuranix owns an exclusive patented technology, based on which two families of products have been designed and developed: vet-wave® and med-wave™.
Transforming the audiological
field with new devices
and clinical excellence
the quality of life
Investing in research
between universities, centers of excellence
and experts in the field
In the animal world, ear pathologies are very common and often underestimated.
Introducing audiology in veterinary, Neuranix provides a new tool for the veterinarian to improve the quality of the diagnosis and the effectiveness of the therapy.
Current technology principles are dated, often very uncomfortable for the patient and not applicable after ear surgery.
By introducing an innovative device not requiring the application of pressure in the ear canal, Neuranix allows the examination to be performed on all categories of patients.
The disruptive and patented technology adopted by Neuranix is based on the analysis of acoustic characteristics of the eardrum and middle ear measured on a wide range of frequencies.